Article & Case Studies

During the BOS Basel 2022 Heidelberg Pharma and CARBOGEN AMCIS presented their collaboration and fully synthetic route for α-Amanitin.

Learn more about our Development & Aseptic Production of Drug Products services with a dedicated case study.

Learn more about our efficient and effective technology transfer process with a dedicated case study.

Franz Amann about CARBOGEN AMCIS' flow chemistry capabilities.

The following case study is one example of how CARBOGEN AMCIS helps customers to advance their projects with a dedicated team and state-of-the-art techniques.

After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for α-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and economical route providing α-Amanitin now available for the development of new therapeutic ADC’s.

Find out more about Simulated Moving Bed chromatography process at CARBOGEN AMCIS AG.